Press Release Archive - RegeneRx

Press Release Archive

Press Release Archive

2010 > 2009 > 2008 > 2007 > 2006 > 2005 > 2004 > 2003 > 2002 > 2001

November 23, 2007
Wall Street Reporter Features Exclusive Video Interviews with CEO’s of BioMS Medical Corp., RegeneRx Biopharmaceuticals, Inc., and Canopus BioPharma

November 5, 2007
German and U.S. Researchers Show TB4’s Cardioprotective Effects in Ischemia-Reperfusion Injury

November 2, 2007
RegeneRx Receives First Ophthalmic Wound-Healing Patent in China

October 30, 2007
RegeneRx President and CEO to Speak at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

October 26, 2007
Two New Research Papers Published on Thymosin Beta 4

October 24, 2007
RegeneRx Recognized as Major Sponsor of “National Epidermolysis Bullosa Awareness Week” Event

October 4, 2007
TB4 Triggers Adult Stem Cells to Form New Blood Vessels and Repair Heart Tissue — Reports U.K. Scientist

October 3, 2007
RegeneRx President and CEO to Speak at BIO InvestorForum 2007

September 18, 2007
RegeneRx, State of Maryland, and University of Maryland, Baltimore Partner to Develop Novel Treatment for Cardiac Reperfusion Injury

September 11, 2007
RegeneRx Receives U.S. Patent for Wound Healing Technology

August 6, 2007
RegeneRx CEO to Air on Live MN1 Interview

July 31, 2007
RegeneRx Biopharmaceuticals, Inc. Updates Clinical Trials Program

July 17, 2007
RegeneRx Biopharmaceuticals, Inc. to Provide Update on Clinical Trials Program

May 9, 2007
RegeneRx to Present at Biotechnology Industry Organization's 2007 Business Forum

May 7, 2007
Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting

May 2, 2007
RegeneRx Receives IND to Begin Cardiovascular Clinical Program

April 30, 2007
RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery

April 25, 2007
RegeneRx to Present at the 20th Annual Symposium On Advanced Wound Care

April 17, 2007
RegeneRx Receives First Patent for Preventing and Repairing Damage to Cardiac Tissue Before, During and After Injury

April 2, 2007
RegeneRx Biopharmaceuticals, Inc. Reports 2006 Year-End Results

March 30, 2007
RegeneRx Files IND to Begin Phase 2 Ophthalmic Clinical Trial

March 30, 2007
RegeneRx Files First IND for Cardiovascular Clinical Program

March 27, 2007
RegeneRx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year End 2006 Earnings Release and Conference Call

March 26, 2007
RegeneRx Reports Preliminary Cardiovascular Data at Thymosin Meeting

March 19, 2007
RegeneRx to Present at First Annual Symposium on Thymosins in Health and Disease

March 12, 2007
Researchers Find that TB4 Increases Gene Expression of Key Wound Healing Enzyme in the Cornea

March 6, 2007
RegeneRx Receives First Patent for Treating Wounds and Other Disorders of the Eye

March 5, 2007
Dr. Deepak Srivastava Joins RegeneRx Medical and Scientific Advisory Board

January 23, 2007
Researchers Find RegeneRx's TB4 Inhibits Activation of Key Inflammatory Molecule - NFkB

January 23, 2007
RegeneRx to Present at the American Stock Exchange's First Annual Healthcare Investor Conference

home|Contact Us|Resources|Site Map|